𝔖 Bobbio Scriptorium
✦   LIBER   ✦

bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer

✍ Scribed by Timothy J. Mackey; Andrew Borkowski; Pradip Amin; Stephen C. Jacobs; Natasha Kyprianou

Book ID
119487517
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
454 KB
Volume
52
Category
Article
ISSN
0090-4295

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Bax, a predictive marker for therapeutic
Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma
✍ Hee Jin Chang; Kyung Hae Jung; Dae Yong Kim; Seung-Yong Jeong; Hyo Seong Choi; Y πŸ“‚ Article πŸ“… 2005 πŸ› Elsevier Science 🌐 English βš– 403 KB

In an attempt to improve local control and survival in patients with advanced rectal carcinoma, neoadjuvant chemoradiation therapy (CRT) has been increasingly used in patient management. However, a significant proportion of patients shows poor response to adjuvant CRT. Thus, the ability to predict C

Thymidine phosphorylase to dihydropyrimi
Thymidine phosphorylase to dihydropyrimidine dehydrogenase ratio as a predictive factor of response to preoperative chemoradiation with capecitabine in patients with advanced rectal cancer
✍ C.S. Boskos; C. Liacos; D. Korkolis; K. Aygerinos; I. Lamproglou; E. Terpos; E. πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 110 KB

## Abstract ## Purpose To identify if thymidine phosphorylase (TP), dihydropyrimidine dehydrogenase (DPD), and ratio TP/DPD levels in tumor tissues are potential predictive factors for response to combined preoperative chemoradiation with capecitabine, in patients with locally advanced rectal canc